Our results demonstrated that the high-adiponectin group had increased omentin levels, multiple CVD risk factors, and non-significantly greater IMT, as compared to the low-adiponectin group of T2D patients. This evidence concerns the gene ITLN1 and type 2 diabetes mellitus.